Success Stories: Illinois-based Manager in the Field of Biostatistics Secures an EB-1A Petition Approval with 114 Citations to His Work (PP Upgrade, No RFE)
Client’s Testimonial:
“Thank you very much!!!!!! I will definitely advertise your company through different forums online and to my friend as well! Because your work are truly great! I cannot make it without your help!”
On July 28th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Manager in the Field of Biostatistics (Approval Notice).
General Field: Biostatistics
Position at the Time of Case Filing: Manager
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Illinois
Approval Notice Date: July 28th, 2016
Processing Time: 120 Days (Premium Processing Requested)
Case Summary:
Largely thanks to Premium Processing (PP), our client did not have to wait between 4-9 months for the USCIS to process his EB-1A (Alien of Extraordinary Ability) petition. PP allowed him to have action taken on his case within 15 calendar days. Although our client waited a total of 120 days before the USCIS granted their approval, it was simply because he did not opt for PP from the very beginning but instead, chose to upgrade his case nearly 4 months after filing. Just 9 days after our client’s case was upgraded to PP, he received notification of case approval.
North America Immigration Law Group (NAILG) was responsible for putting together a strong EB-1A petition packet for our client and here are some of the top points we focused on:
- Citation Count: In order to prove that our client’s findings are important to other researchers in the field of biostatistics, we noted his citation count at the time of filing: 114 citations.
- Publication Record: When we filed the case, our client had 15 peer-reviewed scientific articles, 1 book chapter, and numerous presentations at national and international conferences to his name.
- Peer Review Experience: To further demonstrate his high standing in the field, we noted the 15 times he judged the work of his peers for high impact scientific journals.
- Testimonials: Six of these very same peers contributed recommendation letters in support of our client’s EB-1A petition. These experts agreed to confirm the importance of our client’s work on developing statistical methods for the assessment of clinical trials for new drug development (most notably to the US medical and pharmaceutical sectors). This is what one of these experts stated in his recommendation letter: “His ongoing research is vitally necessary if our medical professionals are to continue to make progress in treating the most challenging diseases, from cancer, to diabetes, to AD.”